Biostratum

Founded with a mission to advance medical research and therapeutic solutions, BioStratum Inc. specializes in developing therapeutic agents targeting basal lamina for the treatment of kidney disease, cancer, and autoimmune diseases. The company offers comprehensive research services aimed at understanding and manipulating basal lamina structures to create effective treatments. BioStratum serves a global market, focusing on providing innovative healthcare solutions that address some of the most challenging medical conditions.

BioStratum has garnered attention for its pioneering work in basal lamina research, attracting notable scientists and investors in the biomedical field. The company's key achievements include significant advancements in therapeutic approaches for kidney disease and cancer, contributing to the broader medical community's understanding of these diseases. Through its impactful research and development efforts, BioStratum has established itself as a crucial player in the biotechnology sector, driving progress in medical treatments and improving patient outcomes worldwide.